Health Trials

Development of an Artificial Intelligence Model for the Identification and Prevention of Smoking-related Diseases.

ConditionsLung Cancer Screening ProgramArtificial Intelligence (AI)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorScientific Institute San Raffaele

About this trial

The study is an interventional pilot study. The study is designed to be monocentric and it presents additional procedues.

Eligibility criteria

Qualifiers

Age >= 50 years old

Active smokers

Former smokers (from no more than 15 years)

Pack/year >20

Disqualifiers

Previous or concurrent neoplastic disease, excluding skin cancers

Cognitive or other problems that could hinder the collection of informed consent

Severe pulmonary or extra pulmonary disease

Previous low-dose computed tomography (CT) scan in the past 12 months

Trial design

Treatments tested in this trial

  • Computed tomography (CT) scan low dose
  • Blood sampling
  • Tissue sampling (lung)
  • Spirometry
  • Questionnaires
  • Smoking cessation program
  • Carbon monoxide measurment
  • Cardiovascular primary prevention

Treatment groups

2,840 Participants
are divided into 4 treatment groups

Sponsors and collaborators

Scientific Institute San Raffaele

Lead sponsor

Source ClinicalTrials.gov